Revised recommendations concerning palivizumab prophylaxis for respiratory syncytial virus (RSV)

Respiratory Syncytial Virus infections are one of the leading causes of severe respiratory diseases that require hospitalization and, in some cases, intensive care. Once resolved, there may be respiratory sequelae of varying severity. The lack of effective treatments for bronchiolitis and the lack o...

Full description

Saved in:
Bibliographic Details
Published in:Ital J Pediatr
Main Authors: Bollani, Lina, Baraldi, Eugenio, Chirico, Gaetano, Dotta, Andrea, Lanari, Marcello, Del Vecchio, Antonello, Manzoni, Paolo, Boldrini, Antonio, Paolillo, Piermichele, Di Fabio, Sandra, Orfeo, Luigi, Stronati, Mauro, Romagnoli, Costantino
Format: Artigo
Language:Inglês
Published: BioMed Central 2015
Subjects:
Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4681171/
https://ncbi.nlm.nih.gov/pubmed/26670908
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13052-015-0203-x
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items